The novel coronavirus disease (COVID-19) has many characteristics common to those in
two other coronavirus acute respiratory diseases, severe acute respiratory syndrome …

An initial cluster of severe viral pneumonia was discovered in early December 2019 in
Wuhan, China. It was found to be caused by a newly identified coronavirus, later named by …

Background Severe COVID‐19 disease is associated with thrombotic complications and
extensive fibrin deposition. This study investigates whether the hemostatic complications in …

The high incidence of thrombotic events suggests a possible role of the contact system
pathway in COVID-19 pathology. In this study, we determined the altered levels of factor XII …

Patients with coronavirus disease-19 (COVID-19) are at high risk for thrombotic arterial and
venous occlusions. However, bleeding complications have also been observed in some …

Coronavirus disease 2019 (COVID-19) has spread, with thrombotic complications being
increasingly frequently reported. Although thrombosis is frequently complicated in septic …

Objective: Coronavirus disease 2019 (COVID-19) is associated with derangement in
biomarkers of coagulation and endothelial function and has been likened to the …

The COVID-19 pandemic has introduced a global public health threat unparalleled in our
history. The most severe cases are marked by ARDS attributed to microvascular thrombosis …

The emerging novel coronavirus disease (COVID-19), which is caused by the SARS-CoV-2
presents with high infectivity, morbidity and mortality. It presenting a need for immediate …

Severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection is a recent
pandemic infectious disease caused by severe acute respiratory syndrome coronavirus …